Characterization of melanoma cells capable of propagating tumors from a single cell.
暂无分享,去创建一个
[1] P. Foubert,et al. Integrin α4β1 signaling is required for lymphangiogenesis and tumor metastasis (Cancer Research (2010) 70, (3042-51) DOI , 2010 .
[2] W. Lu,et al. Tumor site-specific silencing of NF-κB p65 by targeted hollow gold nanosphere-mediated photothermal transfection (Cancer Research (2010) 70, (3177-3188) DOI: 10.1158/0008-5472.CAN-09-3379) , 2010 .
[3] T. Schall,et al. Tumor and Stem Cell Biology Cancer Research The Chemokine Receptor CXCR 7 Is Highly Expressed in Human Glioma Cells and Mediates Antiapoptotic Effects , 2010 .
[4] J. F. Burrows,et al. The deubiquitinating enzyme USP17 is highly expressed in tumor biopsies, is cell cycle regulated, and is required for G1-S progression. , 2010, Cancer research.
[5] M. Kloor,et al. Somatic hypermethylation of MSH2 is a frequent event in Lynch Syndrome colorectal cancers. , 2010, Cancer research.
[6] A. Muotri,et al. Coordination of centrosome homeostasis and DNA repair is intact in MCF-7 and disrupted in MDA-MB 231 breast cancer cells. , 2010, Cancer research.
[7] J. Vincent,et al. 5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity. , 2010, Cancer research.
[8] R. Hoffman,et al. The effect of CXCL12 processing on CD34+ cell migration in myeloproliferative neoplasms. , 2010, Cancer research.
[9] Chris T. Harvey,et al. ID1 enhances docetaxel cytotoxicity in prostate cancer cells through inhibition of p21. , 2010, Cancer research.
[10] J. Heath,et al. Signal transducers and activators of transcription-3 binding to the fibroblast growth factor receptor is activated by receptor amplification. , 2010, Cancer research.
[11] C. Croce,et al. Oncogenic role of miR-483-3p at the IGF2/483 locus. , 2010, Cancer research.
[12] P. Fisher,et al. Molecular mechanism of chemoresistance by astrocyte elevated gene-1. , 2010, Cancer research.
[13] Jing Ma,et al. Immunohistochemical expression of BRCA1 and lethal prostate cancer. , 2010, Cancer research.
[14] G. Mills,et al. Mammalian target of rapamycin activator RHEB is frequently overexpressed in human carcinomas and is critical and sufficient for skin epithelial carcinogenesis. , 2010, Cancer research.
[15] H. Kung,et al. Aberrant activation of the androgen receptor by NF-kappaB2/p52 in prostate cancer cells. , 2010, Cancer research.
[16] J. Chien,et al. Downregulation of HtrA1 promotes resistance to anoikis and peritoneal dissemination of ovarian cancer cells. , 2010, Cancer research.
[17] R. DePinho,et al. BRafV600E cooperates with Pten silencing to elicit metastatic melanoma , 2009, Nature Genetics.
[18] A. Larsson,et al. Serological and immunohistochemical analysis of S100 and new derivatives as markers for prognosis in patients with malignant melanoma , 2008, Melanoma research.
[19] S. Morrison,et al. Efficient tumor formation by single human melanoma cells , 2008, Nature.
[20] J. Visvader,et al. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions , 2008, Nature Reviews Cancer.
[21] J. Visvader,et al. The mammary progenitor marker CD61/beta3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis. , 2008, Cancer research.
[22] M. Todaro,et al. Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity , 2008, Proceedings of the National Academy of Sciences.
[23] Anna E. Lokshin,et al. Drug-Selected Human Lung Cancer Stem Cells: Cytokine Network, Tumorigenic and Metastatic Properties , 2008, PloS one.
[24] T. Mak,et al. Pten deficiency in melanocytes results in resistance to hair graying and susceptibility to carcinogen-induced melanomagenesis. , 2008, Cancer research.
[25] Curt Balch,et al. Identification and characterization of ovarian cancer-initiating cells from primary human tumors. , 2008, Cancer research.
[26] G. Mills,et al. Cancer stem cells contribute to cisplatin resistance in Brca1/p53-mediated mouse mammary tumors. , 2008, Cancer research.
[27] S. Fan,et al. Significance of CD90+ cancer stem cells in human liver cancer. , 2008, Cancer cell.
[28] A. Strasser,et al. Response to Comment on "Tumor Growth Need Not Be Driven by Rare Cancer Stem Cells" , 2007, Science.
[29] F. Luciani,et al. Beta-catenin induces immortalization of melanocytes by suppressing p16INK4a expression and cooperates with N-Ras in melanoma development. , 2007, Genes & development.
[30] R. Schneider-Broussard,et al. Erratum: Hierarchical organization of prostate cancer cells in xenograft tumors: The CD44+α2β1+ cell population is enriched in tumor-initiating cells (Cancer Research (2007) 67, (6796-6805)) , 2007 .
[31] Aleksandar Dakic,et al. Tumor Growth Need Not Be Driven by Rare Cancer Stem Cells , 2007, Science.
[32] R. Schneider-Broussard,et al. Hierarchical Organization of Prostate Cancer Cells in Xenograft Tumors: The CD44+α2β1+ Cell Population Is Enriched in Tumor-Initiating Cells , 2007 .
[33] M. Serrano,et al. A new mouse model to explore the initiation, progression, and therapy of BRAFV600E-induced lung tumors. , 2007, Genes & development.
[34] J. Dick,et al. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice , 2007, Nature.
[35] T. Pietri,et al. Neural crest–derived cells with stem cell features can be traced back to multiple lineages in the adult skin , 2006, The Journal of cell biology.
[36] Mark W. Dewhirst,et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response , 2006, Nature.
[37] Irving L Weissman,et al. Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. , 2006, Cancer research.
[38] L. Chin,et al. Malignant melanoma: genetics and therapeutics in the genomic era. , 2006, Genes & development.
[39] L. Chin,et al. Characterization of melanocyte‐specific inducible Cre recombinase transgenic mice , 2006, Genesis.
[40] P. Dalerba,et al. Identification of pancreatic cancer stem cells. , 2006, Cancer research.
[41] J. Dick,et al. Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity , 2004, Nature Immunology.
[42] Cynthia Hawkins,et al. Identification of a cancer stem cell in human brain tumors. , 2003, Cancer research.
[43] S. Morrison,et al. Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[44] L. Chin,et al. Genetic analysis of Pten and Ink4a/Arf interactions in the suppression of tumorigenesis in mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[45] M. Taketo,et al. Intestinal polyposis in mice with a dominant stable mutation of the β‐catenin gene , 1999, The EMBO journal.
[46] M. Caligiuri,et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice , 1994, Nature.
[47] T. Takemura,et al. Pigment Production in Murine Melanoma Cells Is Regulated by Tyrosinase, Tyrosinase-Related Protein 1 (TRP1), DOPAchrome Tautomerase (TRP2), and a Melanogenic Inhibitor , 1993 .
[48] T. P. Pretlow,et al. Transplantation of human prostatic carcinoma into nude mice in Matrigel. , 1991, Cancer research.
[49] J. Chien,et al. Downregulation of HtrA 1 Promotes Resistance to Anoikis and Peritoneal Dissemination of Ovarian Cancer Cells , 2010 .
[50] J. Dick. Looking ahead in cancer stem cell research , 2009, Nature Biotechnology.
[51] Miriam Scadeng,et al. Development of a novel mouse glioma model using lentiviral vectors , 2009, Nature Medicine.
[52] 玉瀬 玲. Identification of tumor-initiating cells in a highly aggressive brain tumor using promoter activity of nucleostemin , 2009 .
[53] B. Thiers,et al. Identification of cells initiating human melanomas , 2009 .
[54] Zang Ai-hua,et al. Stem Cells,Cancer and Cancer Stem Cells , 2005 .
[55] H. Gaylord,et al. AMERICAN ASSOCIATION FOR CANCER RESEARCH. , 1913, California state journal of medicine.